Provided by Tiger Fintech (Singapore) Pte. Ltd.

Cencora Inc.

283.77
-20.8100-6.83%
Pre-market: 286.783.01+1.06%08:58 EDT
Volume:4.12M
Turnover:1.19B
Market Cap:55.00B
PE:33.05
High:303.13
Open:301.00
Low:282.98
Close:304.58
Loading ...

Here's Why You Should Retain OPKO Health Stock in Your Portfolio

Zacks
·
28 Mar

Press Release: Cencora Announces Date and Time for Second Quarter Fiscal 2025 Earnings Release

Dow Jones
·
28 Mar

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

Zacks
·
27 Mar

Cencora, Inc. (COR) Hit a 52 Week High, Can the Run Continue?

Zacks
·
27 Mar

CAH Stock Rises More Than 13% YTD: Should You Buy, Hold or Sell?

Zacks
·
27 Mar

DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval

Zacks
·
27 Mar

Cencora Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
27 Mar

Deutsche Bank Adjusts Cencora Price Target to $285 From $24

MT Newswires Live
·
27 Mar

GEHC Stock Falls Despite New Launch to Boost Breast Cancer Diagnosis

Zacks
·
24 Mar

GEHC Stock Gains Following Cardiology Solutions Portfolio Expansion

Zacks
·
21 Mar

Is Cellectar Biosciences (CLRB) Stock Outpacing Its Medical Peers This Year?

Zacks
·
18 Mar

4 GARP Stocks That Investors Can Scoop Up for Maximum Returns

Zacks
·
18 Mar

Cencora Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
18 Mar

Beat the Market the Zacks Way: Amgen, DRDGOLD, Anavex in Focus

Zacks
·
17 Mar

Cencora, Inc. (COR): Among Top Insider Sales Last Month

Insider Monkey
·
17 Mar

Wells Fargo Adjusts Price Target on Cencora to $274 From $251, Maintains Equalweight Rating

MT Newswires Live
·
14 Mar

BRIEF-Farminveste Says End Of Offer Period For Bond Loan 2025-2029 Changed To March 17 From March 14

Reuters
·
13 Mar

Cencora (NYSE:COR) Eyes Acquisitions and Technology Investments with Potential OneOncology Buyout

Simply Wall St.
·
12 Mar

Here's Why You Should Avoid Betting on Danaher Stock Right Now

Zacks
·
11 Mar

Here's Why Cencora (COR) is a Strong Value Stock

Zacks
·
11 Mar